The use of TNF-alpha inhibitors is associated with a lower risk of developing primary open-angle glaucoma and requiring certain glaucoma treatments, a study finds.
A molecule linked to chronic inflammation disrupts the brain's ability to create new neurons, uncovering a pathway with therapeutic potential for neurodegenerative diseases and neurological conditions ...
GMP Human TNF-alpha Protein (Cat. No. GMP-TNAH23) is expressed in human 293 cells (HEK293) and comprises amino acids Val 77 to Leu 233 (Accession # P01375). This protein has no "tag". It has a ...
R Dr Eneas de Carvalho Aguiar 470, Instituto de Medicina Tropical (IMT), Cerqueira Cesar, São Paulo, SP, 05403 903, Brazil Tel.: +55 11 3061 7457 Fax: +55 11 3081 7190 mahong@usp.br Establishing that ...
BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and ...
Company holds FDA-cleared Phase 2 INDs for MYMD-1 in two additional chronic inflammatory conditions, rheumatoid arthritis and Hashimoto’s thyroiditis BALTIMORE--(BUSINESS WIRE)--TNF Pharmaceuticals, ...
The authors of a review in Clinical and Experimental Dermatology assessed the association between long-term TNF-α inhibitor (TNFi) therapy and the risk of cancer among 32,765 patients with psoriasis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results